Cross Country Healthcare Future Growth
Future criteria checks 0/6
Cross Country Healthcare's revenue and earnings are forecast to decline at 10.7% and 19.8% per annum respectively. EPS is expected to decline by 18.6% per annum. Return on equity is forecast to be 7.4% in 3 years.
Key information
-19.8%
Earnings growth rate
-18.6%
EPS growth rate
Healthcare earnings growth | 23.4% |
Revenue growth rate | -10.7% |
Future return on equity | 7.4% |
Analyst coverage | Good |
Last updated | 22 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,630 | 58 | N/A | N/A | 2 |
12/31/2025 | 1,537 | 43 | 85 | 94 | 9 |
12/31/2024 | 1,482 | 32 | 89 | 96 | 9 |
12/31/2023 | 2,020 | 73 | 235 | 248 | N/A |
9/30/2023 | 2,234 | 102 | 228 | 241 | N/A |
6/30/2023 | 2,428 | 124 | 298 | 311 | N/A |
3/31/2023 | 2,641 | 156 | 200 | 210 | N/A |
12/31/2022 | 2,807 | 188 | 125 | 134 | N/A |
9/30/2022 | 2,819 | 227 | 47 | 56 | N/A |
6/30/2022 | 2,558 | 216 | -95 | -87 | N/A |
3/31/2022 | 2,136 | 175 | -98 | -90 | N/A |
12/31/2021 | 1,677 | 132 | -93 | -86 | N/A |
9/30/2021 | 1,252 | 59 | -16 | -10 | N/A |
6/30/2021 | 1,071 | 34 | -21 | -16 | N/A |
3/31/2021 | 956 | 9 | -20 | -15 | N/A |
12/31/2020 | 836 | -13 | 23 | 27 | N/A |
9/30/2020 | 836 | -19 | 15 | 20 | N/A |
6/30/2020 | 851 | -21 | 10 | 14 | N/A |
3/31/2020 | 837 | -58 | 7 | 10 | N/A |
12/31/2019 | 822 | -58 | 3 | 6 | N/A |
9/30/2019 | 808 | -76 | 7 | 10 | N/A |
6/30/2019 | 800 | -74 | 24 | 28 | N/A |
3/31/2019 | 801 | -20 | 16 | 21 | N/A |
12/31/2018 | 816 | -17 | 16 | 21 | N/A |
9/30/2018 | 835 | 31 | 34 | 39 | N/A |
6/30/2018 | 863 | 38 | 34 | 38 | N/A |
3/31/2018 | 868 | 41 | 52 | 57 | N/A |
12/31/2017 | 865 | 38 | 40 | 46 | N/A |
9/30/2017 | 868 | 2 | N/A | 27 | N/A |
6/30/2017 | 854 | 9 | N/A | 43 | N/A |
3/31/2017 | 845 | -13 | N/A | 29 | N/A |
12/31/2016 | 834 | 8 | N/A | 30 | N/A |
9/30/2016 | 804 | 10 | N/A | 32 | N/A |
6/30/2016 | 785 | 1 | N/A | 25 | N/A |
3/31/2016 | 778 | 21 | N/A | 21 | N/A |
12/31/2015 | 767 | 4 | N/A | 18 | N/A |
9/30/2015 | 762 | -10 | N/A | 18 | N/A |
6/30/2015 | 756 | -22 | N/A | 7 | N/A |
3/31/2015 | 686 | -28 | N/A | 5 | N/A |
12/31/2014 | 618 | -32 | N/A | -4 | N/A |
9/30/2014 | 539 | -64 | N/A | -6 | N/A |
6/30/2014 | 458 | -55 | N/A | -1 | N/A |
3/31/2014 | 446 | -54 | N/A | 1 | N/A |
12/31/2013 | 438 | -54 | N/A | 9 | N/A |
9/30/2013 | 441 | -4 | N/A | 16 | N/A |
6/30/2013 | 445 | -5 | N/A | 11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XXY's earnings are forecast to decline over the next 3 years (-19.8% per year).
Earnings vs Market: XXY's earnings are forecast to decline over the next 3 years (-19.8% per year).
High Growth Earnings: XXY's earnings are forecast to decline over the next 3 years.
Revenue vs Market: XXY's revenue is expected to decline over the next 3 years (-10.7% per year).
High Growth Revenue: XXY's revenue is forecast to decline over the next 3 years (-10.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: XXY's Return on Equity is forecast to be low in 3 years time (7.4%).